Disease Area

dermatitis atopic

Atopic dermatitis is a chronic, relapsing inflammatory skin disease characterised by intense pruritus and eczematous lesions, affecting up to 20% of children and 10% of adults. The therapeutic landscape has been transformed by dupilumab and other IL-4/IL-13 antagonists, as well as JAK inhibitors for moderate-to-severe disease. Research into the skin microbiome, barrier restoration, and comorbid allergic disease continues to refine management.

Dermatitis Atopic
Does dupilumab increase lymphoma risk in eczema patients?
Dupilumab, a common eczema treatment, has raised questions about its potential link to lymphoma. Data suggests no increased risk, but vigilance remains key.
Get the full story
12 min read
Dermatitis Atopic
TSW Controversy: Mitochondrial NAD Excess Identified, Diagnostic Clarity Emerges
Topical steroid withdrawal (TSW) is a distinct syndrome, not merely a flare of underlying dermatoses, with new research identifying mitochondrial NAD excess as a targetable mechanism.
Get the full story
9 min read
Dermatitis Atopic
Prior Authorization Delays Atopic Dermatitis Treatment Access
Prior authorization requirements for atopic dermatitis therapies delay patient access, leading to disease exacerbation and increased healthcare costs.
Get the full story
13 min read
Dermatitis Atopic
Goat Milk Formula Linked With Less Atopic Dermatitis
Infants fed goat milk formula demonstrated a reduced incidence of atopic dermatitis compared to those on cow milk formula, according to recent observations.
Get the full story
8 min read

Loading articles...